about
Understanding the burden of influenza infection among adults in Canadian hospitals: a comparison of the 2009-2010 pandemic season with the prepandemic and postpandemic seasons.Trends in antiviral therapy of adults hospitalized with influenza in Canada since the end of the 2009 pandemic.Impact of the 2009 influenza A (H1N1) pandemic on Canadian health care workers: a survey on vaccination, illness, absenteeism, and personal protective equipment.Laboratory-confirmed pandemic h1n1 influenza in hospitalized adults: findings from the Canadian Nosocomial Infections Surveillance Program, 2009-2010.Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006.Antimicrobial susceptibilities of health care-associated and community-associated strains of methicillin-resistant Staphylococcus aureus from hospitalized patients in Canada, 1995 to 2008Prevalence of antimicrobial use in a network of Canadian hospitals in 2002 and 2009.Hypervirulent Clostridium difficile strains in hospitalized patients, CanadaComparative genomics of Canadian epidemic lineages of methicillin-resistant Staphylococcus aureus.The emerging epidemiology of VRE in Canada: results of the CNISP Passive Reporting Network, 1994 to 1998.Mupirocin-resistant, methicillin-resistant Staphylococcus aureus strains in Canadian hospitals.Assessing the magnitude and trends in hospital acquired infections in Canadian hospitals through sequential point prevalence surveys.A preliminary guideline for the assignment of methicillin-resistant Staphylococcus aureus to a Canadian pulsed-field gel electrophoresis epidemic type using spa typingMethicillin-resistant Staphylococcus aureus colonization or infection in Canada: National Surveillance and Changing Epidemiology, 1995-2007.Determinants of Outcome in Hospitalized Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: Results From National Surveillance in Canada, 2008-2012.Surveillance for healthcare-acquired febrile respiratory infection in pediatric hospitals participating in the Canadian Nosocomial Infection Surveillance Program.Periprosthetic Infection following Primary Hip and Knee Arthroplasty: The Impact of Limiting the Postoperative Surveillance Period.Healthcare-Associated Clostridium difficile Infections and Strain Diversity in Pediatric Hospitals in the Canadian Nosocomial Infection Surveillance Program, 2007-2011.Complete Sequence of Four Multidrug-Resistant MOBQ1 Plasmids Harboring blaGES-5 Isolated from Escherichia coli and Serratia marcescens Persisting in a Hospital in Canada.Complete sequences of a novel blaNDM-1-harbouring plasmid from Providencia rettgeri and an FII-type plasmid from Klebsiella pneumoniae identified in Canada.Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolates.Healthcare-associated influenza in Canadian hospitals from 2006 to 2012.Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study.Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP).National surveillance of methicillin-resistant Staphylococcus aureus among hospitalized pediatric patients in Canadian acute care facilities, 1995-2007.Are health care workers protected? An observational study of selection and removal of personal protective equipment in Canadian acute care hospitals.Infection control practices related to Clostridium difficile infection in acute care hospitals in Canada.Infection prevention and control practices related to Clostridium difficile infection in Canadian acute and long-term care institutions.Vancomycin-resistant enterococci in Canada: results from the Canadian nosocomial infection surveillance program, 1999-2005.Clinical and epidemiologic features of methicillin-resistant Staphylococcus aureus in elderly hospitalized patients.Infection control and antimicrobial restriction practices for antimicrobial-resistant organisms in Canadian tertiary care hospitals.A point prevalence survey of health care-associated infections in pediatric populations in major Canadian acute care hospitals.Molecular epidemiology of vancomycin-resistant enterococcal bacteraemia: results from the Canadian Nosocomial Infection Surveillance Program, 1999-2009.ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates.Antimicrobial resistance surveillance in Canadian hospitals, 2007-2012.The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009-2015).
P50
Q30355105-E3654B80-9E79-4C18-8D99-C72335D0CEF1Q30357688-BA51F501-8A47-4C86-A52B-8A21D953F72AQ30416637-7D023BDD-FFD4-4BA3-93A8-63E3429CA55DQ30421072-BEE5CBD9-5D1D-489C-943D-1818FF1C2231Q33613735-61FDE857-42B3-419C-A1F3-C3D2E2D1E632Q33826253-56B4A16F-99B5-4FBA-8371-1C82299A9021Q35569879-A696196A-121F-46E5-B606-74259FF13256Q35877207-CFAFCEEE-3813-4C65-ADFB-E99562923895Q35913839-8D03B94A-CAF4-4E8D-BF28-432C795A1F66Q36170453-4DE51822-C140-40EA-8670-C7A93295C7BEQ36295497-C7B7C3A4-4943-45AC-BCB9-92F435C62421Q36923519-F6651389-11BC-4226-B0C9-2FC346A48803Q37018230-A137A664-9631-4008-A607-79AFF7068E66Q37690736-2BD61923-A481-4EF4-8D61-735365A21338Q40092092-31BD8ED4-5F60-439E-A54A-B16349B3EEE7Q40387767-79B35A60-7F07-4D91-944E-B5E409864371Q40456560-DFE5271F-DF9B-484B-A092-8CC0C50807B3Q40981809-6131BAC6-04DD-4ACC-8965-9C879A3AFBAAQ41578602-E16395EB-48B8-4DCE-9F76-06CE64437123Q42630046-C30F1A65-1276-4A97-B1D9-3850664996B9Q43131316-C58369A5-9D10-444F-9180-264085A5B4EAQ43869108-0302BE61-3CAC-4389-B477-584311C21CBAQ43945760-DAAA9A6D-5050-47C3-AA26-75FC37EB02C5Q44458638-C39E2080-CB0A-4359-BD3E-D896BB78B096Q44687965-1A78D937-AC25-4562-9C8E-8D2BB9A1E82CQ44818474-10F94FF2-9AA4-463F-BC39-10E7529DDE5CQ44958937-EC094F48-6928-49FE-AE40-A4D283936D12Q46141476-BE1273F4-E6EE-4183-8F7E-9CE8542C0407Q46778271-94E55AC9-17B1-47BE-9043-4447D12B1C8CQ46795761-5A4C4CE5-127E-4C6B-8C18-67BAF85835B3Q50658945-F1E95818-1328-4682-920D-BD079DDC9510Q51025595-AD1AC3B4-6728-4B8F-A06D-B50C1C44EEB8Q54266977-F1BB1EFE-7E81-4AB3-841A-BD5681B01EEDQ54446040-6D29149E-6B40-4502-BC6A-237B436CE5FBQ55035042-E9EDCD2D-6B42-43A6-A509-5F846CF0FFB7Q55377810-A6789AB7-7A93-42B0-8D32-8422BC7F6619
P50
description
Organisation
@de
name
Canadian Nosocomial Infection Surveillance Program
@en
type
label
Canadian Nosocomial Infection Surveillance Program
@en
prefLabel
Canadian Nosocomial Infection Surveillance Program
@en